Marketing-authorisation holder · United States
United Therap
6 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
6 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ORENITRAM0.125mg base | 0.25mg base | 1mg base | 2.5mg base | 5mg base · Tablet, extended release | Treprostinil | United States | Marketed | 2013 |
| REMODULIN0.1mg/ml | 0.2mg/ml | 0.4mg/ml | 10mg/ml | 1mg/ml | 2.5mg/ml | 20mg/ml | 5mg/ml · Injectable | Treprostinil | United States | Marketed | 2002 |
| REMODULIN100mg/20ml (5mg/ml) | 200mg/20ml (10mg/ml) | 20mg/20ml (1mg/ml) | 50mg/20ml (2.5mg/ml) · Solution | Treprostinil | United States | Not marketed | 2018 |
| TYVASO0.6mg/ml · Solution | Treprostinil | United States | Marketed | 2009 |
| TYVASO DPI0.016mg/inh | 0.032mg/inh | 0.048mg/inh | 0.064mg/inh | 0.08mg/inh · Powder | Treprostinil | United States | Marketed | 2022 |
| UNITUXIN17.5mg/5ml · Injectable | Dinutuximab beta | United States | Marketed | 2015 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|